STAT+: Dutch antitrust regulators probe Biogen over test for its MS drug
Dutch anti-trust regulators are investigating allegations that Biogen may have abused its dominant position in the market for multiple sclerosis treatments and associated blood tests. The Netherlands Authority for Consumers and Markets, also known…
ImpactNotable
Published2 h ago (Tue, 10 Nov 2026 13:38:35 GMT)
AuthorEd Silverman
MoreLess
Impact score33/100
RatingRule-based estimate: no strong signals; trust 8/10.
RegionsGlobal
Retrievedvia rss
ClassifiedTue, 10 Nov 2026 14:02:44 GMT by heuristic